We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
and moving into new territory with good momentum. Looks like 600p hasn't been a ceiling for now despite a strong run recently. I will have to reassess my Target Price here as we look to be in breakout mode.,
Hhaha these brokers go which ever way the wind is blowing. Miserly upside on that rating but should be further gains here for the patient. It is tempting to try and trade it after a strong rise but decent companies like this are hard to find. I said below the share dip was crazy and it is only now we are heading to fair value.
broker target increased to 615p
https://www.britishbulls.com/m/SignalPage.aspx?lang=en&Ticker=RWS.L
My max buy in price has arrived and its minimum value with the ask on 602p. Should I sell or hang on in the hope of further rises? I can usually read this one like a book but trying to know when to sell or hang on for more is all greek to me.
some nice profits for RWS. The initial jump was warranted so the current measly 4.24% rise is certainly a buying opportunity in any man's language. Once again the market is not valuing this company correctly as it is at least worth 600p. I will be adding here until the market is up to date with the events.
Me Too :D
and the market is still not up with events. "Considerably ahead" and "excellent start" warrants more than a 2.3% rise. I expect this to power through 500p in time. Happy to be a buyer here at least up to 500p.
Broke through 500p and put on a spurt to 514p.Certainly feels like a momentum play now. If Moravia can carry forward its impressive trading as well as driving synergies I can see this translating into an SP of 550 to 560p. We still have the benefit of the US tax reform to come which should benefit EPS and cash generation.
Anyone got a target price here?
Now we all know true value ---------- :D gl all invstors - dont sell - this good long term investment for income
Difference a day makes' a song?
Well seems I got that one wrong ("soon" turned into a month) just been looking at the technical/chart hopefully the next target is about 425 (the 200 day moving average) followed by 430 (a support level from Dec last year) Going long
Sorry not much to add except the prior Tradings statement (6 Oct) the share price shot up 18%. 6 months later after the half year (24 Apr)Trading statement the share price drops 17% ref http://www.londonstockexchange.com/exchange/prices-and-markets/stocks/exchange-insight/news-analysis.html?fourWayKey=GB00BVFCZV34GBGBXAMSM Personally i think a 5% recovery should be possible soon rather than later
Ok it has taken a currency hit but a 14% fall on slightly below market expectations forecast translates into a bit of an over-reaction. The P/E was a bit racy so not much margin for error but I think well worth investing in for the recovery.
RWS RWS Holdings <b><u>LATEST BROKER VIEWS</u></b> Date Broker New target Recomm. 6 Dec Numis 490.00 Add 6 Dec Shore Capita lN/A Hold 29 Nov Berenberg 530.00 Buy https://pbs.twimg.com/media/DSJEpJmXcAINZvM.jpg
RWS RWS Holdings, SP breaking through the rising ascending triangle into the chart space above. SP target former top shown on chart. Stock is not cheap but is quality. https://pbs.twimg.com/media/DSIoCdqW0AAAHit.jpg
RWS Holdings broker views........... DateBrokerRecommendationPriceOld target priceNew target priceNotes 06 Dec 17 Numis Add 428.75 490.00 490.00 Upgrades 06 Dec 17 Shore Capital Hold 428.75 -- Reiterates 29 Nov 17 Berenberg Buy 428.75 -530.00 Initiates/Starts
RWS Rws Holdings...tipped by questor in the telegpaph. <b>Questor: buy IHT-free RWS as it tightens its hold on patent services for blue-chips</b> Sam Brodbeck 8 DECEMBER 2017 • 8:01AM Patents may not sound the sexiest of investments but these crucial legal documents hold the key to billions of pounds of corporate earnings. Just ask Catherine Hettinger, the American creator of the “fidget spinners” now selling from a corner shop near you to legions of British schoolchildren. Ms Hettinger has not earned a penny from the millions of sales after she surrendered the patent for her design in 2005 because she could not afford the £300 renewal fee. On a rather grander scale, it is this kind of “intellectual property” that the world’s largest companies, in particular those that operate in pharmaceuticals and technology, rely on. Multinational firms need watertight patents filed in the many markets they operate in and that is where today’s addition to Questor’s new Inheritance Tax Portfolio can help. Listed on the junior Aim market, RWS Holdings is the market leader in translating intellectual property rights. It has a particular focus on companies in the life sciences sector, such as biotechnology, cosmetics and food processing firms. Patent filing is becoming more international, according to RWS, with three-quarters of the firm’s clients now filing in four or more countries. An excellent example of a business with Warren Buffett’s favoured “economic moats”, the company is used by all of the most frequent patent filers, which like the expertise offered by its staff of multilingual science graduates. Likewise, RWS is found in many of the “IHT portfolios” now offered by investment firms to clients who want to minimise death duties. Like Questor’s IHT portfolio, these include companies likely to qualify for “business property relief” and therefore able to be passed on tax free on death if held for at least two years. HM Revenue & Customs does not keep a list of firms that qualify for this relief, and the stock must have tax-exempt status in the same tax year as the death. For that reason it is impossible to say for certain that an investment will be entirely tax free but RWS’s inclusion in the portfolios of wealth managers such as Investec and Octopus Investments is comforting. Octopus, for instance, employs auditor PwC to monitor the IHT status of its investments. Octopus fund manager Richard Power has held RWS since his firm launched its IHT service in 2005. Power told Questor he was still buying the shares despite the 24pc rise in the price since January. “RWS has raised its profits and dividends ever since it listed in 2003, even through the financial crisis,” he said. “It’s a very reliable underlying business, not very exposed to economic cycles. “
Rights Issue When a company offers new shares pro rata to its own shareholders, usually at a discount.
So they already placed 20%. That explains the drop Thanks!
Surely the SP fell by nearly 20% this morning because they just placed new shares to the value of 20% of the company?
This might be a stupid question but what did you mean by "...fear RI for the acquisition?".
Drop occurred because Investors fear RI for the acquisition?
The half-year results came in as expected with profits growing thanks to the recent two big acquisitions. However, if analysts forecast is right for 2017, it means trailing adjusted P/E of 29 times. In 2018, adjusted EPS rises by 14.4 pence, a 6% increase, giving a 2-year trailing P/E of 27.5 times. The average P/E in the last 11 years is 18 times with the lows at 8 times, during the financial crisis. If you want to read my analysis on RWS Holding and why this company is a best-kept secret for so long, then the link is http://bit.ly/2rM6UQe For those long-term holders, this stock is a hold because of its attractive dividends. BTW, if you held this stock for 11 years, your yield on costs would have risen from 2.8% to 13.54% and the capital appreciation is equivalent to a 10-bagger!